# Alcohol quantity mediates the association between daily alcohol and cannabis co-use and alcohol consequences. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/alcohol-cannabis-co-use-consequences-alcohol-quantity-mediation/ > **Published:** 2026-03-24T21:03:48-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:56-04:00 > **Clinical Summary:** Explore how alcohol cannabis co-use consequences are mediated by alcohol quantity, highlighting key harm reduction strategies for young adults. --- CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic Polysubstance UseAlcohol[Harm Reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/)Young AdultsClinical Study Journal Drug and alcohol dependence Study Type Clinical Study Population Human participants Why This Matters This study clarifies a critical mechanistic pathway in alcohol-cannabis co-use patterns that directly impacts clinical [risk assessment](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/). Understanding that increased alcohol consumption mediates the relationship between co-use and negative consequences provides actionable targets for [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) counseling. Clinical Summary This 28-day ecological momentary assessment study of 115 young adults with frequent alcohol and [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) examined day-level associations between co-use and alcohol-related consequences. Using multilevel mediation models, researchers found that increased alcohol quantity significantly mediated the relationship between co-use days and both positive and negative alcohol consequences. The within-person design strengthens causal inference by controlling for individual-level confounders. The study addresses previous inconsistencies in co-use research by explicitly accounting for alcohol quantity as a mediating variable. Dr. Caplan’s Take “This confirms what we observe clinically – patients who combine substances often escalate their primary substance of concern, creating compounding risks. The mediation pathway gives us a concrete intervention point: addressing alcohol quantity specifically on co-use occasions.” Clinical Perspective 🧠 Clinicians should assess co-use patterns specifically and counsel patients that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) days often correlate with increased alcohol consumption and associated harms. Harm reduction strategies should focus on alcohol quantity limits during co-use occasions rather than targeting co-use itself. This evidence supports quantity-focused interventions over abstinence-only approaches for young adults engaging in polysubstance use. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Alcohol%20quantity%20mediates%20the%20association%20between%20daily%20alcohol%20and%20cannabis%20co-...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41546986/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41546986/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Alcohol%20quantity%20mediates%20the%20association%20between%20daily%20alcohol%20and%20cannabis%20co-...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41546986/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41546986/](https://pubmed.ncbi.nlm.nih.gov/41546986/) Table of Contents - [FAQ](#FAQ)[What is alcohol and cannabis co-use, and how common is it among young adults?](#What_is_alcohol_and_cannabis_co-use_and_how_common_is_it_among_young_adults) - [Does using alcohol and cannabis together lead to drinking more alcohol?](#Does_using_alcohol_and_cannabis_together_lead_to_drinking_more_alcohol) - [What types of consequences are associated with alcohol-cannabis co-use?](#What_types_of_consequences_are_associated_with_alcohol-cannabis_co-use) - [Should I be concerned about patients who use alcohol and cannabis together?](#Should_I_be_concerned_about_patients_who_use_alcohol_and_cannabis_together) - [What harm reduction strategies should I discuss with patients who co-use alcohol and cannabis?](#What_harm_reduction_strategies_should_I_discuss_with_patients_who_co-use_alcohol_and_cannabis) - [Related](#Related) ## FAQ #### What is alcohol and cannabis co-use, and how common is it among young adults? Alcohol and cannabis co-use refers to the concurrent or simultaneous use of both substances, either on the same day or during the same occasion. This pattern is particularly common among young adults who frequently use both substances, with research showing it’s associated with increased likelihood of experiencing both positive and negative alcohol-related consequences. #### Does using alcohol and cannabis together lead to drinking more alcohol? Yes, this study found that on days when young adults used both alcohol and cannabis together, they consumed significantly more alcoholic drinks compared to alcohol-only days. The increased alcohol consumption appears to be the primary mechanism explaining why co-use leads to more alcohol-related consequences. #### What types of consequences are associated with alcohol-cannabis co-use? Co-use is associated with both positive consequences (such as enhanced social experiences or relaxation) and negative consequences (including impaired judgment, risky behaviors, or physical harm). The study found that the increased alcohol quantity consumed during co-use days mediates the relationship between co-use and both types of consequences. #### Should I be concerned about patients who use alcohol and cannabis together? Yes, co-use warrants clinical attention as it leads to increased alcohol consumption and associated consequences. Healthcare providers should assess for polysubstance use patterns and implement harm reduction strategies focused on moderating alcohol quantity when patients engage in co-use behaviors. #### What harm reduction strategies should I discuss with patients who co-use alcohol and cannabis? Focus on alcohol quantity management since increased drinking appears to drive most negative consequences during co-use. Recommend strategies like setting drink limits before using either substance, alternating with non-alcoholic beverages, and avoiding co-use on high-risk occasions where excessive drinking is more likely. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Alcohol quantity mediates the association between daily alcohol and cannabis co-use and alcohol consequences.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41546986/”, “about”: “drug alcohol dependence clinical study alcohol”, “isPartOf”: “Drug and alcohol dependence”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Alcohol quantity mediates the association between daily alcohol and cannabis co-use and alcohol consequences.](https://cedclinic.com/cannabis-alcohol-co-use-consequences-research-quantity-mediation/) A detailed exploration of how alcohol quantity influences the relationship between alcohol and cannabis co-use and its consequences. [Read More](https://cedclinic.com/cannabis-alcohol-co-use-consequences-research-quantity-mediation/) [Cannabis Use Disorder Treatment Europe Review](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) Review of current evidence on [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) treatments available in Europe, highlighting clinical approaches and outcomes. [Explore Treatments](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) [Alcohol and Tobacco More Harmful Than Marijuana, Government Study Confirms (2026)](https://cedclinic.com/alcohol-tobacco-harm-comparison-government-study-2026/) Government research confirms the relative harms of alcohol and tobacco compared to marijuana, informing [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) policies. [Learn More](https://cedclinic.com/alcohol-tobacco-harm-comparison-government-study-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).